Filing Details
- Accession Number:
- 0001104659-15-081527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-25 17:05:28
- Reporting Period:
- 2015-11-24
- Filing Date:
- 2015-11-25
- Accepted Time:
- 2015-11-25 17:05:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Ophthotech Corp. | OPHT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277966 | Chandrakant Samir Patel | C/O Ophthotech Corporation One Penn Plaza, 19Th Floor New York NY 10119 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-24 | 1,532 | $1.65 | 280,137 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-11-24 | 25,683 | $31.29 | 305,820 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-24 | 19,371 | $60.14 | 286,449 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-24 | 7,844 | $60.60 | 278,605 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | Disposition | 2015-11-24 | 1,532 | $0.00 | 1,532 | $1.65 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2015-11-24 | 25,683 | $0.00 | 25,683 | $31.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,180 | 2022-04-08 | No | 4 | M | Direct | |
| 87,500 | 2024-01-01 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2015.
- These shares were disposed of in multiple transactions on November 24, 2015 at actual sales prices ranging from $59.48 to $60.465 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on November 24, 2015 at actual sales prices ranging from $60.48 to $60.775 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option was granted on April 9, 2012 and vests over four years, with 2.0833% of the original number of shares underlying the option vesting monthly from the date of grant.
- This option was granted on January 2, 2014 and vests over four years, with 25% of the original number of shares underlying the option vested on the first anniversary of the date of grant, and 2.0833% of the original number of shares underlying the option vesting monthly thereafter.
Billionaire Hedge Funds
